SARS-CoV-2 uses CD4 to infect T helper lymphocytes

Area of Science:

• Immunology
• Virology
• Cell Biology

Background:

• Coronavirus Disease 2019 (COVID-19), caused by SARS-CoV-2, primarily affects the lungs.
• Immune complications like lymphocytopenia and cytokine storm are linked to COVID-19 severity and mortality.
• The precise mechanisms of SARS-CoV-2-induced immune dysfunction remain unclear.

Purpose of the Study:

• To investigate the interaction between SARS-CoV-2 and human T cells.
• To elucidate the role of CD4+ T helper cells in SARS-CoV-2 infection.
• To understand how SARS-CoV-2 impacts immune response in severe COVID-19.

Main Methods:

• Analysis of T cells from blood and bronchoalveolar lavage of severe COVID-19 patients.
• Investigation of SARS-CoV-2 spike glycoprotein (S) binding to CD4 molecule.
• Assessment of T helper cell function and cytokine expression post-infection.

Main Results:

• SARS-CoV-2 was found to infect CD4+ T helper cells, but not CD8+ T cells.
• The SARS-CoV-2 spike protein directly binds to the CD4 molecule, facilitating viral entry into T helper cells.
• Infected T helper cells exhibited impaired function, potential cell death, and elevated IL-10 levels, correlating with viral persistence and disease severity.

Conclusions:

• CD4-mediated entry of SARS-CoV-2 into T helper cells contributes to immune system dysfunction.
• This mechanism may explain the poor immune response observed in severe COVID-19 patients.
• Targeting the CD4 interaction could be a potential therapeutic strategy.